Comments
MediciNova asthma drug fails trial; shares crash
24.05.2012. | (Reuters) - Biopharmaceutical company MediciNova Inc said its experimental asthma drug failed to meet the main goal of a second mid-stage trial, sending its shares down as much as 51 percent in extended trade....
